Lyka Labs Ltd

Lyka Labs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Lyka Labs Ltd

₹ 62.9 -3.17%
23 Jul - close price
lykalabs.com BSE: 500259 NSE: LYKALABS
About

Incorporated in 1976, Lyka Labs Ltd is in the development, manufacture and marketing of quality finished dosages[1]

Key Points

Business Overview:[1]
LLL is a WHO-GMP certified and ISO 9001- certified manufacturer of Pharmaceutical Formulations & Active Pharmaceutical Ingredients across various therapeutic segments, including Lyophilized injections, topical formulations of cream, ointment, foams, gels & lotions.

Website BSE NSE - BE
  • Market Cap ₹ 225 Cr.
  • Current Price ₹ 62.9
  • High / Low ₹ 121 / 44.1
  • Stock P/E
  • Book Value ₹ 25.9
  • Dividend Yield 0.00 %
  • ROCE -5.98 %
  • ROE -10.2 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company's working capital requirements have reduced from 32.4 days to 22.7 days

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 8.29% over past five years.
  • Company has a low return on equity of -2.04% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
22.24 22.88 27.99 32.56 27.77 30.11 41.16 33.80 33.43 33.03 36.66 30.73 28.03
18.94 20.24 23.82 25.69 25.75 26.40 36.21 28.61 29.35 29.35 39.20 29.08 34.48
Operating Profit 3.30 2.64 4.17 6.87 2.02 3.71 4.95 5.19 4.08 3.68 -2.54 1.65 -6.45
OPM % 14.84% 11.54% 14.90% 21.10% 7.27% 12.32% 12.03% 15.36% 12.20% 11.14% -6.93% 5.37% -23.01%
0.02 0.38 -0.18 0.54 0.32 0.56 0.03 0.83 0.82 0.63 1.09 1.16 0.61
Interest 2.85 1.35 1.19 1.28 1.07 0.65 0.54 0.61 0.47 0.85 0.79 0.82 0.70
Depreciation 3.47 3.47 3.59 2.84 2.90 1.76 1.76 1.83 1.42 2.11 2.15 2.15 2.04
Profit before tax -3.00 -1.80 -0.79 3.29 -1.63 1.86 2.68 3.58 3.01 1.35 -4.39 -0.16 -8.58
Tax % 0.00% 7.22% -22.78% 38.60% 28.22% 30.65% 28.36% 24.30% 32.89% 26.67% -26.65% -6.25% -6.06%
-3.01 -1.85 -0.49 1.78 -2.09 1.29 1.91 2.70 2.03 0.99 -3.22 -0.15 -8.07
EPS in Rs -0.98 -0.56 -0.15 0.54 -0.63 0.40 0.59 0.76 0.50 0.26 -0.94 0.00 -2.13
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Jun 2015 Mar 2016 9m Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
166 130 110 60 71 61 86 194 93 111 138 128
139 110 87 63 73 65 67 93 76 95 121 132
Operating Profit 28 20 23 -4 -2 -4 20 101 17 16 18 -3
OPM % 17% 16% 21% -6% -3% -6% 23% 52% 18% 14% 13% -3%
4 8 -2 4 1 -30 0 -4 -4 1 2 4
Interest 24 15 19 10 7 20 26 20 12 5 2 3
Depreciation 11 9 10 11 7 8 8 17 14 13 7 8
Profit before tax -3 4 -8 -20 -15 -62 -14 59 -13 -1 11 -12
Tax % 31% -5% -19% -5% -59% 1% -29% 35% -0% 182% 29% -11%
-5 4 -7 -19 -6 -63 -10 38 -13 -3 8 -10
EPS in Rs -2.29 1.67 -2.51 -6.14 -1.97 -21.10 -4.03 13.59 -4.30 -0.75 2.24 -2.81
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 0%
5 Years: 8%
3 Years: 11%
TTM: -7%
Compounded Profit Growth
10 Years: %
5 Years: 1%
3 Years: -32%
TTM: -226%
Stock Price CAGR
10 Years: -2%
5 Years: 0%
3 Years: -16%
1 Year: -44%
Return on Equity
10 Years: %
5 Years: %
3 Years: -2%
Last Year: -10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Jun 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 22 22 22 28 28 29 29 29 31 33 36 36
Reserves 20 22 16 21 15 -43 -54 -15 15 35 69 57
137 121 126 113 96 141 163 130 75 59 39 49
100 77 88 67 76 73 52 42 31 30 32 33
Total Liabilities 279 242 252 229 216 200 190 186 152 157 176 175
122 104 133 116 108 105 98 94 68 58 85 87
CWIP 27 30 24 28 31 28 26 18 16 23 1 2
Investments 0 0 0 0 0 0 0 0 0 0 0 0
130 107 94 85 77 68 66 74 67 76 90 86
Total Assets 279 242 252 229 216 200 190 186 152 157 176 175

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Jun 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
27 12 31 11 27 5 9 79 9 2 2 5
37 17 -13 -3 -4 -0 -0 -6 7 -9 -12 -9
-60 -30 -19 -10 -23 3 -12 -63 -22 2 5 4
Net Cash Flow 4 -1 -0 -3 -1 9 -3 10 -5 -6 -5 0
Free Cash Flow 55 28 18 7 23 4 8 72 15 -7 -10 -6
CFO/OP 97% 60% 143% -318% -1,462% -131% 49% 79% 52% 21% 28% -159%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Jun 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 124 121 97 125 75 48 37 35 79 89 114 100
Inventory Days 77 56 90 139 65 69 41 56 68 78 82 99
Days Payable 220 218 266 301 216 192 141 96 91 98 98 122
Cash Conversion Cycle -18 -41 -79 -37 -75 -76 -63 -5 55 68 97 76
Working Capital Days -220 -242 -357 -735 -265 -242 -118 -121 -0 23 51 23
ROCE % 10% 7% 9% -8% -5% -6% 10% 61% 5% 4% 10% -6%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Domestic Revenue Share (Consolidated)
% of consolidated revenue

Log in to view insights

Please log in to see hidden values.

Login
Permanent Employees
count ・Standalone data
R&D Investment / Spend
INR Lakhs ・Standalone data
Number of Major Customers (>10% of revenue)
count ・Standalone data
Product Registrations Received (New + Renewals)
count ・Standalone data
New Product Registration Applications Submitted
count ・Standalone data
Lyophilisation Capacity Expansion
% of existing capacity ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

16 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
54.81% 54.81% 54.81% 58.11% 58.11% 58.11% 58.16% 58.16% 58.16% 58.16% 58.16% 58.45%
0.18% 0.17% 0.17% 0.15% 0.15% 0.15% 0.24% 0.16% 0.17% 0.17% 0.29% 0.17%
0.41% 0.62% 0.81% 0.75% 0.66% 0.66% 0.66% 0.66% 0.66% 0.66% 0.66% 0.66%
44.61% 44.41% 44.21% 40.99% 41.08% 41.07% 40.93% 41.02% 40.99% 40.99% 40.89% 40.73%
No. of Shareholders 26,65226,42225,71725,71628,94329,09928,47228,18927,74327,15526,72729,369

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings